Uhlinova Jana, Pechter Ulle, Kermes Kadri, Ots-Rosenberg Mai
Department of Internal Medicine, University of Tartu, 6 Puusepa Street, Tartu 51014, Estonia.
Int J Nephrol. 2011;2011:470426. doi: 10.4061/2011/470426. Epub 2011 Jun 15.
Peritoneal dialysis (PD) has been intensively offered at our centre to patients (pts) with end-stage renal disease (ESRD) from 2000, and the number of PD pts was noticed to raise. We aimed to analyse the PD population from the aspect of penetration and peritonitis rate during eleven years. Cumulative number of new RRT pts was 378 during the study period. We found high PD penetration rate: 53% (range 32-72%). The rate of peritonitis was as high as 9.8 during first study years, but it has declined progressively last year being 29.1 by September 2010 and 21.7 by December 2010. Most cases of peritonitis were due to gram-positive pathogens. We have demonstrated steady high single-centre PD penetration rate and improvement of management of patients during last decade probably because of the result of better pts education and a continued dedication of the staff.
自2000年起，我们中心就一直积极地为终末期肾病（ESRD）患者提供腹膜透析（PD）治疗，并且发现接受PD治疗的患者数量有所增加。我们旨在分析11年间PD患者群体的透析普及率和腹膜炎发生率。研究期间新接受肾脏替代治疗（RRT）的患者累计有378例。我们发现透析普及率很高：达53%（范围为32%-72%）。在研究的最初几年，腹膜炎发生率高达9.8，但去年逐渐下降，到2010年9月为29.1，到2010年12月为21.7。大多数腹膜炎病例是由革兰氏阳性病原体引起的。我们证明了在过去十年中，单中心的PD普及率持续保持在较高水平，并且患者管理有所改善，这可能得益于对患者更好的教育以及工作人员的持续奉献。
